# Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

> **NCT01367301** · NA · TERMINATED · sponsor: **Albert Einstein College of Medicine** · enrollment: 14 (actual)

## Conditions studied

- Stage IA Uterine Sarcoma
- Stage IB Uterine Sarcoma
- Stage IC Uterine Sarcoma
- Stage IIA Uterine Sarcoma
- Stage IIB Uterine Sarcoma
- Stage IIIA Uterine Sarcoma
- Stage IIIB Uterine Sarcoma
- Stage IIIC Uterine Sarcoma
- Stage IVA Uterine Sarcoma
- Stage IVB Uterine Sarcoma
- Uterine Carcinosarcoma

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** carboplatin
- **RADIATION:** external beam radiation therapy
- **RADIATION:** brachytherapy
- **RADIATION:** intensity-modulated radiation therapy
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01367301
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07-08
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-08-15
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Lack of accrual. PI left the institution
- **Last updated:** 2023-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367301, "Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01367301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*